Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
featured
A phase II study of Antineoplastons A10 And AS2-1 Private In Children With Primary Malignant Brain Tumors

A phase II study of Antineoplastons A10 And AS2-1 Private In Children With Primary Malignant Brain Tumors

  • 136 views
  • 08 Nov, 2020
  • 1 location
Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma

structures) and focal radiotherapy. A large number of chemotherapeutic agents (e.g. alkylating agents such as TMZ and nitrosoureas such as carmustine) have also been tested, but they display limited efficacy

temozolomide
brain tumor
nitrosoureas
therapeutic agent
carmustine
  • 59 views
  • 15 Feb, 2021
  • 12 locations
Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors

Background Researchers want to find better ways to treat cancer. One drug that treats cancer is paclitaxel. Sometimes proteins block that drug from working. Researchers want to see if another drug, nilotinib, helps paclitaxel work better. Objective To test the safety of nilotinib plus paclitaxel and find out what doses …

neutrophil count
paclitaxel
liver metastasis
nitrosoureas
advanced cancer
  • 0 views
  • 01 Aug, 2021
  • 1 location
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel

Background People with rare cancers often have limited treatment options. The biology of rare cancers is not well understood. Researchers want to find better treatments for these cancers. They want to test 2 drugs that, taken separately, have helped people with non-rare cancers. They want to see if these drugs …

solid neoplasm
neutrophil count
primary cancer
bisphosphonate
sarcoma
  • 0 views
  • 14 Jun, 2021
  • 1 location